(CAHC) –
-
LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp.
-
CA Healthcare Acquisition (CAHC) and LumiraDx Announces Effectiveness of Merger Registration; Schedules Special Shareholder Meeting for September 28th, 2021
-
CA Healthcare Acquisition Corp. and LumiraDx Limited Announce Effectiveness of Registration Statement and September 28, 2021 Special Meeting to Approve Business Combination
-
Ladenburg Thalmann Starts CA healthcare Acquisition Corp. (CAHC) at Buy
-
LumiraDx and CA Healthcare Acquisition Corp (CAHC) Revise Transaction Terms
-
LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics
-
Pre-Open Stock Movers 04/07: (SOS) (NMTR) (UTME) Higher; (FGEN) (GEO) (FIXX) Lower (more...)
-
LumiraDx to List on Nasdaq via Merger with CA Healthcare Acquisition Corp (CAHC)
-
LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp
-
CA Healthcare Acquisition Corp. (CAHC) Prices 10M Unit IPO at $10/Unit
Back to CAHC Stock Lookup